Subscribe Alumni Newsroom Offices Contact Us About Us Careers
Sectors
Sectors
Practice Areas
People
Insights
Events
LearningLab

Popular Searches

Back
In the News

Foley’s Announcement of New Orlando Team Receives Widespread Media Coverage

March 25, 2022

People

A man in a pinstripe suit, blue shirt, and patterned red tie poses for a professional headshot in an office setting, reflecting the polished image of lawyers in Chicago.

Todd A. Miller

Orlando 407.236.5875
A man in a dark suit and striped tie stands in front of a blurred corporate law office, looking at the camera with a neutral expression—reflecting the professionalism of top Chicago lawyers.

Andrew Finkelstein

Orlando 407.236.5882
A man in a dark suit, white shirt, and patterned tie stands in front of a blurred corporate law office background, looking at the camera with a neutral expression.

Richard M. Caron

Orlando 407.236.5873
A woman with long brown hair, wearing glasses, a white top, and a black blazer, smiling in front of a plain gray background—perfectly reflecting the professional atmosphere of leading law offices in Chicago.

Kylie J. Mullen

Orlando 407.236.5880

Related News

View All Posts
September 18, 2026 In the News

Patrick Daugherty Authors Article on Navigating Proposed SEC Crypto Asset Regulations

Foley & Lardner LLP partner Patrick Daugherty authored the Columbia Law School’s Blue Sky Blog article, “How to Advise Token Developers in Light of Proposed SEC Regulation Crypto Assets.”
September 17, 2026 In the News

Foley Featured in Law.com for Guiding Kontoor Brands in Sale of Lee®

Foley & Lardner LLP partner Bryan Schultz is featured for leading the Foley deal team which advised Kontoor Brands in the sale of its Lee® business in Law.com's “How the Deal Got Done” series.
September 15, 2026 In the News

David Rosen Shares Insights on FDA Efforts to Accelerate Human Clinical Trials

Foley & Lardner LLP partner David Rosen shared insights in the recent Law360 article, “FDA Seeks Applications For Project To Speed Up Human Trials,” on the FDA's pilot program pairing pharmaceutical companies with research institutions to accelerate human clinical trials.